SignalHealth curates the day's regulatory moves and the industry-leader commentary that interprets them — into concise, fully-sourced briefs. Every claim is one click from its primary source, so you can act on it.
Every brief links out to the rule, ballot, or post it summarizes. Lead with trust.
We surface proposed rules, draft specs and RFIs that are open for industry feedback — before they're final.
We track dozens of agency feeds and expert newsletters, then focus each edition on what compliance and interoperability teams need to act on.
Comments close in 2 days (Oct 9)
FDA Proposes Reclassifying Digital Breast Tomosynthesis Systems from Class III to Class II
Comments close in 6 days (Oct 13)
CMS proposes RAPID coverage pathway for accelerated Medicare device coverage
Comments close in 9 days (Oct 16)
FDA Proposes Downgrading Bladder Cancer Detection Endoscopes from Class III to Class II
The finalized model applies international price comparisons to Medicare Part B drugs, potentially reshaping reimbursement for oncology and specialty therapies. The Centers for Medicare & Medicaid Services (CMS) has finalized the Most Favored Nation (MFN) Model, which aims to align Medicare Part B...
Teal Health raises funding to prepare for increased demand as CMS requires health plans to cover self-collected tests at no cost starting in 2027. Teal Health has raised $22 million in funding to prepare for an expected surge in demand stemming from a new federal coverage mandate.
Fact sheet outlines ONC's enhanced monitoring, complaint handling, and sanctioning processes for health IT developers under the 2015 Edition certification program. The Office of the National Coordinator for Health IT (ONC) has published an updated fact sheet detailing its Certification Program...
Let SignalHealth do the aggregation, summarizing, and sourcing.
Create free account